查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1480366

到 2033 年免疫诊断的全球市场机会与策略

Immunodiagnostics Global Market Opportunities And Strategies To 2033
出版日期: | 出版商: The Business Research Company | 英文 296 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2018年全球免疫诊断市场价值为146.464亿美元，到2023年复合年增长率将超过7.0%。

医疗支出增加

医疗保健支出的成长推动了业绩期间免疫诊断市场的扩张。卫生支出对于推动创新和改善先进技术的取得至关重要。随着医疗保健预算的增加，对先进诊断技术（包括免疫诊断）的需求激增，这些技术在疾病检测和监测中发挥着至关重要的作用。支出的增加使医疗机构能够投资最先进的设备和创新的诊断解决方案，从而推动市场成长。根据管理医疗保险和医疗补助等美国主要医疗保健计划的美国联邦机构医疗保险和医疗补助服务中心的数据，2020 年美国医疗保健支出增长 9.7%，达到 4.1 兆美元1，相当于每人 12,530 美元。 2020 年，英国医疗保健支出占国内生产总值(GDP) 的比例为 19.7%，即 2,690 亿英镑（3,544.5 亿美元），比 2019 年支出名目增加 20%。因此，医疗保健支出的增加推动了免疫诊断市场的成长。

目录

第一章执行摘要

  • 免疫诊断 - 市场吸引力和宏观经济条件

第二章 目录

第三章表格一览

第四章图表一览

第五章 报告结构

第六章市场特点

  • 一般市场定义
  • 概述
  • 免疫诊断市场定义与细分
  • 按产品细分市场
    • 试剂及耗材
    • 装置
    • 软体和服务
  • 市场区隔：按技术
    • 酵素免疫分析法
    • 化学冷光免疫检测
    • 萤光免疫分析法
    • 免疫检测
    • 快速诊断
    • 其他的
  • 市场区隔：按应用
    • 感染疾病
    • 肿瘤学和内分泌学
    • 骨骼和矿物质疾病
    • 自体免疫疾病
    • 心臟生物标记
    • 肝炎和逆转录病毒检测
    • 其他的
  • 市场区隔：按最终用户
    • 医院
    • 诊所
    • 诊断实验室
    • 学术研究所
    • 其他的

第七章 主要市场趋势

  • 采用照护现场免疫诊断来提供快速结果
  • 利用 DNA 扩增技术提高免疫检测灵敏度
  • 市场参与企业之间的策略伙伴关係

第八章免疫诊断市场：宏观经济情景

  • COVID-19 的影响：免疫诊断市场
  • 乌克兰战争的影响：免疫诊断市场
  • 高通膨的影响：免疫诊断市场

第九章世界市场规模与成长

  • 市场规模
  • 2018-2023 年市场成长表现
    • 市场驱动因素，2018-2023
    • 市场限制，2018-2023
  • 2023-2028 年、2033 年市场成长预测
    • 2023-2028 年市场驱动因素
    • 市场限制，2023-2028

第十章全球免疫诊断市场：细分

  • 全球免疫诊断市场：按产品、性能和预测，2018-2023、2028、2033
  • 全球免疫诊断市场：按应用、效能和预测，2018-2023、2028、2033
  • 全球免疫诊断市场：最终用户的表现和预测，2018-2023、2028、2033
  • 全球免疫诊断市场：依技术分類的表现与预测，2018-2023、2028、2033

第十一章免疫诊断市场：区域/国家分析

  • 全球免疫诊断市场：按地区、绩效和预测，2018-2023、2028、2033
  • 全球免疫诊断市场：依国家、绩效及预测，2018-2023、2028、2033

第十二章亚太市场

第十三章西欧市场

第十四章 东欧市场

第十五章 北美市场

第十六章 南美洲市场

第十七章 中东市场

第十八章 非洲市场

第十九章 竞争格局及公司概况

  • 公司简介
  • Abbott Laboratories
  • F. Hoffman-La Roche Ltd
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • DiaSorin SpA

第20章 竞争基准化分析

第 21 章竞争对手仪表板

第二十二章 重大併购

  • Novacyt Acquired Yourgene Health
  • Freenome Acquired Oncimmune Ltd.
  • DiaSorin SpA Acquired Luminex Corporation
  • Avacta Group plc Acquired Launch Diagnostics Holdings Limited
  • Heska Acquired LightDeck Diagnostics

第23章机会与策略

  • 2028 年全球免疫诊断市场：提供新机会的国家
  • 2028 年全球免疫诊断市场：提供新机会的细分市场
  • 2028 年全球免疫诊断市场：成长策略
    • 根据市场趋势制定策略
    • 竞争对手的策略

第24章免疫诊断市场：结论与建议

  • 结论
  • 推荐
    • 产品
    • 地方
    • 价格
    • 晋升
    • 人力资源

第25章附录

简介目录
Product Code: o&s1166

Immunodiagnostics refers to a branch of medical diagnostics that utilizes antibodies to detect diseases or conditions. This field relies on the specific interactions between antigens (substances that stimulate an immune response) and antibodies (specific binding proteins produced by immune cells in response to antigens). Immunodiagnostic tests can identify the presence of antigens produced by pathogens such as viruses, bacteria or parasites, as well as detect proteins produced by the body in response to pathogens or pathological changes in organs, tissues and cells in response to disease or injury.

The immunodiagnostics market consists of sales, by entities (organizations, sole traders and partnerships), of immunodiagnostics products and services that utilize the antibodies to detect and measure specific substances through antigen-antibody reactions.

The global immunodiagnostics market was valued at $14,646.4 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 7.0%.

Rise In Healthcare Expenditure

The rise in healthcare expenditure drove the expansion of the immunodiagnostics market during the historic period. Healthcare expenditure is essential for driving innovation and improving access to advanced technologies. As healthcare budgets increased, there was a corresponding surge in demand for advanced diagnostic technologies, including immunodiagnostics, which played a pivotal role in disease detection and monitoring. This increased expenditure allowed healthcare facilities to invest in state-of-the-art equipment and innovative diagnostic solutions, driving market growth. According to the Centers for Medicare & Medicaid Services, a US-based federal agency that administers the nation's major healthcare programs including Medicare and Medicaid, health spending in the USA grew by 9.7% in 2020, reaching $4.1 trillion or $12,530 per person. As a share of the nation's Gross Domestic Product, health spending accounted for 19.7% of GDP in the UK in 2020, which is £269 billion ($354.45 billion), a nominal-terms increase of 20% on spending in 2019. Therefore, the rise in healthcare expenditure propelled the growth of the immunodiagnostics market.

Increasing Immunoassay Sensitivity Using DNA Amplification Technology

Companies operating in immunodiagnostics are increasing immunoassay sensitivity using DNA amplification technology. This approach involves amplifying target DNA sequences associated with specific biomarkers, thereby increasing the detectability of analytes in biological samples. By integrating DNA amplification techniques such as polymerase chain reaction (PCR), into immunoassay platforms, companies can achieve greater sensitivity and accuracy in detecting low-concentration analytes. For instance, in May 2021, Cavidi, a Sweden-based pharmaceutical and diagnostic company, introduced a groundbreaking platform technology called Exazym, signal generating technology to bring ultra-sensitive detection-levels to conventional immunodiagnostic assays. This innovative technology offers a novel signal amplification method known as Binding Oligo Ladder Detection (BOLD), which significantly enhances immunoassay signal amplification by up to 100 times.

The global immunodiagnostics market is fairly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up to 23.25% of the total market in 2022.

Immunodiagnostics Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global immunodiagnostics market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for immunodiagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The immunodiagnostics market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider immunodiagnostics market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by technology, by application and by end-user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the immunodiagnostics market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis - Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, by technology, by application and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Benchmarking - Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard - Briefs on competitive dashboard of major players.
  • Key Mergers And Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for immunodiagnostics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups next five years.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Product: Reagents And Consumables; Instruments; Software And Services
  • 2) By Technology: Enzyme-Linked Immunosorbent Assay; Chemiluminescence Immunoassay; Fluorescent Immunoassay; Radioimmunoassay; Rapid Test; Other Technologies
  • 3) By Application: Infectious Diseases; Oncology And Endocrinology; Bone And Mineral Diseases; Autoimmunity Disorders; Cardiac Biomarkers; Hepatitis And Retrovirus Testing; Other Applications
  • 4) By End-User: Hospitals; Clinics; Diagnostic Laboratories; Academic And Research Institutes; Other End-Users
  • Companies Mentioned: Abbott Laboratories;F. Hoffmann-La Roche Ltd;Thermo Fisher Scientific Inc.; Danaher Corporation; DiaSorin S.p.A.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; immunodiagnostics indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Immunodiagnostics - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Immunodiagnostics Market Definition And Segmentations
  • 6.4 Market Segmentation By Product
    • 6.4.1 Reagents And Consumables
    • 6.4.2 Instruments
    • 6.4.3 Software And Services
  • 6.5 Market Segmentation By Technology
    • 6.5.1 Enzyme-Linked Immunosorbent Assay
    • 6.5.2 Chemiluminescence Immunoassay
    • 6.5.3 Fluorescent Immunoassay
    • 6.5.4 Radioimmunoassay
    • 6.5.5 Rapid Test
    • 6.5.6 Other Technologies
  • 6.6 Market Segmentation By Application
    • 6.6.1 Infectious Diseases
    • 6.6.2 Oncology And Endocrinology
    • 6.6.3 Bone And Mineral Diseases
    • 6.6.4 Autoimmune Disorders
    • 6.6.5 Cardiac Biomarkers
    • 6.6.6 Hepatitis And Retrovirus Testing
    • 6.6.7 Other Applications
  • 6.7 Market Segmentation By End-User
    • 6.7.1 Hospitals
    • 6.7.2 Clinics
    • 6.7.3 Diagnostic Laboratories
    • 6.7.4 Academic And Research Institutes
    • 6.7.5 Other End Users

7 Major Market Trends

  • 7.1 Introduction Of Point-Of-Care Immunodiagnostics To Provide Rapid Results
  • 7.2 Increasing Immunoassay Sensitivity Using DNA Amplification Technology
  • 7.3 Strategic Partnership Among Market Players

8 Immunodiagnostics Market - Macro Economic Scenario

  • 8.1 COVID-19 Impact On The Immunodiagnostics Market
  • 8.2 Impact Of The War In Ukraine On The Immunodiagnostics Market
  • 8.3 Impact Of High Inflation On The Immunodiagnostics Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Immunodiagnostics Market Segmentation

  • 10.1 Global Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.4 Global Immunodiagnostics Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Immunodiagnostics Market, Regional and Country Analysis

  • 11.1 Global Immunodiagnostics Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Immunodiagnostics Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate Tax Structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Asia-Pacific Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.6 Asia-Pacific Immunodiagnostics Market: Country Analysis
  • 12.7 China Market
  • 12.8 Summary
  • 12.9 Market Overview
    • 12.9.1 Country Information
    • 12.9.2 Market Information
    • 12.9.3 Background Information
    • 12.9.4 Government Initiatives
    • 12.9.5 Taxes Levied
    • 12.9.6 Regulations
    • 12.9.7 Regulatory Bodies
    • 12.9.8 Major Associations
    • 12.9.9 Corporate Tax Structure
    • 12.9.10 Investments
    • 12.9.11 Major Companies
  • 12.10 China Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 China Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.12 China Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Market
  • 12.14 India Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 India Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.16 India Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Market
  • 12.18 Japan Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Japan Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.20 Japan Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Market
  • 12.22 Australia Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Australia Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.24 Australia Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Market
  • 12.26 Indonesia Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 Indonesia Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.28 Indonesia Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Market
  • 12.30 South Korea Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.31 South Korea Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.32 South Korea Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate tax structure
    • 13.2.10 Investments
    • 13.2.11 Major Companies
  • 13.3 Western Europe Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.6 Western Europe Immunodiagnostics Market: Country Analysis
  • 13.7 UK Market
  • 13.8 UK Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 UK Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.11 Germany Market
  • 13.12 Germany Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 Germany Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.15 France Market
  • 13.16 France Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 France Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.19 Italy Market
  • 13.20 Italy Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Italy Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.23 Spain Market
  • 13.24 Spain Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.26 Spain Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Major Companies
  • 14.3 Eastern Europe Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.6 Eastern Europe Immunodiagnostics Market: Country Analysis
  • 14.7 Russia Market
  • 14.8 Russia Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.10 Russia Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Investments
    • 15.2.11 Major Companies
  • 15.3 North America Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.6 North America Immunodiagnostics Market: Country Analysis
  • 15.7 USA Market
  • 15.8 Summary
  • 15.9 Market Overview
    • 15.9.1 Country Information
    • 15.9.2 Market Information
    • 15.9.3 Background Information
    • 15.9.4 Government Initiatives
    • 15.9.5 Regulations
    • 15.9.6 Regulatory Bodies
    • 15.9.7 Major Associations
    • 15.9.8 Taxes Levied
    • 15.9.9 Corporate Tax Structure
    • 15.9.10 Investments
    • 15.9.11 Major Companies
  • 15.10 USA Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 USA Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.12 USA Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Market
  • 15.14 Canada Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.15 Canada Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.16 Canada Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Investment
    • 16.2.11 Major Companies
  • 16.3 South America Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.6 South America Immunodiagnostics Market: Country Analysis
  • 16.7 Brazil Market
  • 16.8 Brazil Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.10 Brazil Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Investments
    • 17.2.11 Major Companies
  • 17.3 Middle East Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.5 Middle East Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
  • 18.2 Market Overview
    • 18.2.1 Region Information
    • 18.2.2 Market Information
    • 18.2.3 Background Information
    • 18.2.4 Government Initiatives
    • 18.2.5 Regulations
    • 18.2.6 Regulatory Bodies
    • 18.2.7 Major Associations
    • 18.2.8 Taxes Levied
    • 18.2.9 Corporate Tax Structure
    • 18.2.10 Investments
    • 18.2.11 Major Companies
  • 18.3 Africa Immunodiagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Immunodiagnostics Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.5 Africa Immunodiagnostics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Abbott Laboratories
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial Overview
  • 19.3 F. Hoffman-La Roche Ltd
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 Thermo Fisher Scientific Inc.
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 Danaher Corporation
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 DiaSorin S.p.A.
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Business Strategy
    • 19.6.4 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Novacyt Acquired Yourgene Health
  • 22.2 Freenome Acquired Oncimmune Ltd.
  • 22.3 DiaSorin S.p.A Acquired Luminex Corporation
  • 22.4 Avacta Group plc Acquired Launch Diagnostics Holdings Limited
  • 22.5 Heska Acquired LightDeck Diagnostics

23 Opportunities And Strategies

  • 23.1 Global Immunodiagnostics Market In 2028 - Countries Offering Most New Opportunities
  • 23.2 Global Immunodiagnostics Market In 2028 - Segments Offering Most New Opportunities
  • 23.3 Global Immunodiagnostics Market In 2028 - Growth Strategies
    • 23.3.1 Market Trend Based Strategies
    • 23.3.2 Competitor Strategies

24 Immunodiagnostics Market, Conclusions And Recommendations

  • 24.1 Conclusions
  • 24.2 Recommendations
    • 24.2.1 Product
    • 24.2.2 Place
    • 24.2.3 Price
    • 24.2.4 Promotion
    • 24.2.5 People

25 Appendix

  • 25.1 Geographies Covered
  • 25.2 Market Data Sources
  • 25.3 Research Methodology
  • 25.4 Currencies
  • 25.5 The Business Research Company
  • 25.6 Copyright and Disclaimer